HSP90 inhibition has also shown potential beyond the cancer field, for example, as a broad-spectrum antiviral approach (9) (including activity against SARS-CoV2 (10)), and as a gero-protection strategy for healthier aging (11, 12). Here, HSP90AA1 is linked to cancer.